Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

Helei Hou,* Kang Qin,* Yu Liang, Chuantao Zhang, Dong Liu, Haiping Jiang, Kewei Liu, Jingjuan Zhu, Hongying Lv, Tianjun Li, Xiaochun ZhangDepartment of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People’s Republic of China*These authors cont...

Full description

Bibliographic Details
Main Authors: Hou H, Qin K, Liang Y, Zhang C, Liu D, Jiang H, Liu K, Zhu J, Lv H, Li T, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Cancer Management and Research
Subjects:
TP53
Epidermal growth factor receptor
Tyrosine kinase inhibitors
Non-small-cell lung cancer
Mutation
Exon
Online Access:https://www.dovepress.com/concurrent-tp53-mutations-predict-poor-outcomes-of-egfr-tki-treatments-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/concurrent-tp53-mutations-predict-poor-outcomes-of-egfr-tki-treatments-peer-reviewed-article-CMAR

Similar Items